Johnson & Johnson
Swiss ExchangeTotal Valuation
Johnson & Johnson carries a market capitalization of - -, placing it among publicly traded companies globally. Its enterprise value stands at 602.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | - - |
| Enterprise Value | 602.53B |
Share Statistics
Johnson & Johnson currently has 2.41B shares outstanding.
| Shares Outstanding | 2.41B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Johnson & Johnson trades at a trailing price-to-earnings ratio of 27.07. The price-to-sales ratio is 5.91, and the price-to-book ratio stands at 182.56.
| PE Ratio | 27.07 |
| PS Ratio | 5.91 |
| PB Ratio | 182.56 |
| P/TBV Ratio | -34.66 |
| P/FCF Ratio | 20.32 |
| P/OCF Ratio | 24.91 |
Enterprise Valuation
On an enterprise value basis, Johnson & Johnson trades at an EV/EBITDA multiple of 17.97 and an EV/FCF ratio of 20.63. The EV/Sales ratio of 6.25 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.36 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.25 |
| EV / EBITDA | 17.97 |
| EV / EBIT | 23.36 |
| EV / FCF | 20.63 |
Financial Position
Johnson & Johnson maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 67.73, indicating elevated leverage, while an interest coverage ratio of 32.27 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.03 |
| Quick Ratio | 0.77 |
| Debt / Equity | 67.73 |
| Debt / EBITDA | 1.64 |
| Interest Coverage | 32.27 |
Financial Efficiency
Johnson & Johnson posts a return on equity of 674.36 and a return on invested capital of 16.03.
| Return on Equity (ROE) | 674.36 |
| Return on Assets (ROA) | 10.66 |
| Return on Invested Capital (ROIC) | 16.03 |
| Return on Capital Employed (ROCE) | 38.63 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.28 |
Taxes
Over the trailing twelve months, Johnson & Johnson has paid 3.90B in income taxes, reflecting an effective tax rate of 15.64.
| Income Tax | 3.90B |
| Effective Tax Rate | 15.64 |
Stock Price Statistics
Johnson & Johnson's stock has gained approximately 4.83553% over the past 52 weeks. The 50-day moving average sits at 184.19, while the 200-day moving average is 184.24.
| Beta (5Y) | N/A |
| 52-Week Price Change | 4.83553% |
| 50-Day Moving Average | 184.19 |
| 200-Day Moving Average | 184.24 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Johnson & Johnson generated 96.36B in revenue and converted that into 21.04B in net income, yielding earnings per share of 8.65. EBITDA reached 33.53B, while operating income came in at 25.79B.
| Revenue | 96.36B |
| Gross Profit | 65.36B |
| Operating Income | 25.79B |
| Pretax Income | 24.94B |
| Net Income | 21.04B |
| EBITDA | 33.53B |
| EBIT | 25.79B |
| Earnings Per Share (EPS) | 8.65 |
Balance Sheet
Johnson & Johnson holds 22.05B in cash and equivalents against 54.99B in total debt, resulting in a net debt position of 33.30B. Total book value stands at 3.12B, with working capital of 1.46B providing operational flexibility.
| Cash & Cash Equivalents | 22.05B |
| Total Debt | 54.99B |
| Net Debt | 33.30B |
| Equity (Book Value) | 3.12B |
| Book Value Per Share | 1.30 |
| Working Capital | 1.46B |
Cash Flow
Johnson & Johnson produced 22.87B in operating cash flow over the past twelve months. After subtracting -5.46B in capital expenditures, free cash flow totaled 17.41B - equivalent to 7.23 per share.
| Operating Cash Flow | 22.87B |
| Capital Expenditures | -5.46B |
| Free Cash Flow | 17.41B |
| FCF Per Share | 7.23 |
Margins
Johnson & Johnson operates with a gross margin of 67.82, reflecting its pricing power and cost economics. The operating margin of 26.77 and net profit margin of 21.83 provide insight into operational efficiency.
| Gross Margin | 67.82 |
| Operating Margin | 26.77 |
| Pretax Margin | 25.88 |
| Profit Margin | 21.83 |
| EBITDA Margin | 34.79 |
Dividends & Yields
The company's payout ratio of 59.52 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 5.20 |
| Dividend Yield | N/A |
| Payout Ratio | 59.52 |
| Shareholder Yield | 2.71 |
| FCF Yield | 4.92 |
Scores
Johnson & Johnson posts an Altman Z-Score of 4.63, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.63 |